Characterizing the gene mutations associated with resistance to gatifloxacin in Mycobacterium tuberculosis through whole-genome sequencing

Jing Bi,Qinglong Guo,Xiangdong Fu,Juan Liang,Lidong Zeng,Min Ou,Juanjuan Zhang,Zhaoqin Wang,Yicheng Sun,Lei Liu,Guoliang Zhang
DOI: https://doi.org/10.1016/j.ijid.2021.09.028
IF: 12.073
2021-11-01
International Journal of Infectious Diseases
Abstract:ObjectivesGatifloxacin (GAT), as one of the representatives of the fourth-generation fluoroquinolones (FQs) has been used to treat drug-resistant tuberculosis. Although DNA gyrase mutations are the leading cause of FQs resistance, mutations conferring resistance to GAT remain inadequately characterized.MethodsIn the present study, GAT-resistant mutants were selected from 7H10 agar plates containing 0.5 mg/L GAT (the critical concentration). Mutations involved in GAT resistance were identified through whole-genome sequence.ResultsA total of 123 isolates were demonstrated to resistance to GAT. Among those isolates, 55.3% (68/123) mutants had gyrA gene mutations (G280A (D94N), A281G (D94G), G280T (D94Y) and G262T (G88C)). The remain (44.7%, 55/123) harbored gyrB gene mutations (A1495G (N499D), C1497A (N499K), C1497G (N499K) and A1503C (E501D)).ConclusionsIn summary, mutations in gyrA and gyrB are the primary mechanism of GAT resistance. The findings provides new insight of resistance to GAT and contribute to molecular diagnosis of GAT resistance in the clinical setting.
infectious diseases
What problem does this paper attempt to address?